RNAC - Cartesian Therapeutics Inc

9.02
2.170   24.058%

Share volume: 2,923,114
Last Updated: 03-09-2026
Pharmaceutical Products/Pharmaceutical Preparations: 3.20%

PREVIOUS CLOSE
CHG
CHG%
$6.85
2.17
0.32%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Overview Charts Financials Fundamental analysis Historical prices Events Documents Notes Dividends
Income statement Balance sheet Cash flow To see more then 2 years history Buy Premium
View ratios

Fiscal Date 03-31-2024 06-30-2024 09-30-2024 12-31-2024 03-31-2025 06-30-2025 09-30-2025
Fiscal Quarter Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025
Report Date 05-08-2024 08-08-2024 11-07-2024 03-13-2025 05-08-2025 08-07-2025 11-06-2025
Total revenue 5.840 M 33.445 M 387.000 K -759.000 K 1.100 M 298.000 K 452.000 K
Cost of revenue 0.000 0.000 0.000 0.000 0.000 0.000 0.000
Gross profit 5.840 M 33.445 M 387.000 K -759.000 K 1.100 M 298.000 K 452.000 K
    472.69% -98.84% -296.12% 244.93% -72.91% 51.68%  
Operating expenses 19.188 M 19.688 M 17.962 M 18.393 M 22.989 M 22.109 M 21.518 M
Selling general and admin 9.450 M 7.027 M 6.562 M 7.087 M 8.315 M 7.240 M 7.716 M
Research and development 9.738 M 12.661 M 11.400 M 11.306 M 14.674 M 14.869 M 13.802 M
Total expenses 19.188 M 19.688 M 17.962 M 25.972 M 22.989 M 22.109 M 21.518 M
    2.61% -8.77% 44.59% -11.49% -3.83% -2.67%  
Operating income -13.348 M 13.757 M -17.575 M -26.731 M -21.889 M -21.811 M -21.066 M
Ebit -13.348 M 13.757 M -27.006 M -26.731 M -19.725 M 14.143 M -37.450 M
Pretax income -56.824 M 14.952 M -24.433 M -10.324 M -17.710 M 15.891 M -35.902 M
    -126.31% -263.41% -57.75% 71.54% -189.73% -325.93%  
Income tax 0.000 0.000 0.000 0.000 0.000 0.000 0.000
Net income basic -56.824 M 0.000 0.000 0.000 0.000 0.000 0.000
    100.00%            
Net income -56.824 M 13.836 M -24.183 M -10.253 M -17.710 M 15.886 M -35.902 M
    124.35% -274.78% 57.60% -72.73% 189.70% -326.00%